Effectiveness and safety of direct acting antivirals for the management of patients with chronic hepatitis C virus in Thailand : A real-life multicenter study.
Not Applicable
- Conditions
- 1.End of treatment response (ETR) is the rate of treatment response. At the temple at the time of study discontinuance Which is divided into biochemical responses (with liver enzymes,ALT) and virologDAA.Chornic hepatitis C.
- Registration Number
- TCTR20200313005
- Lead Sponsor
- one
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Enrolling by invitation
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
1. Patients aged 18 years and older who are admitted to institutions participating in the chronic hepatitis C research project during the year 2015-present
2. Patients are treated with Direct Acting Antivirals and may or may not be combined with ribavirin.
Exclusion Criteria
1. Patients younger than 18 years of age
2. Pregnant patients.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method fibrosis stage 1 year Assessments that indicate significant fibrosis
- Secondary Outcome Measures
Name Time Method /A N/A N/A